Leading Financial Service Provider in India | Canara Bank Securities Ltd

BAFNA PHARMACEUTICALS LTD.

NSE CodeBAFNAPHBE
BSE Code532989
ISININE878I01022
IndustryPharmaceuticals

130.85+ 6.20 (4.97%) In BSE

455 Volume

129.80 Open Price

124.65 Prev. Close

0.00 (0) Bid. Price (Qty.)

0.00 (0) Offer. Price (Qty.)

130.85

Today's Low / High

129.80

130.20

52 Wk Low / High

67.80

View Chart

131.61+ 6.26 (4.99%) In NSE

10714 Volume

131.61 Open Price

125.35 Prev. Close

0.00 (0) Bid. Price (Qty.)

0.00 (0) Offer. Price (Qty.)

131.61

Today's Low / High

131.61

129.10

52 Wk Low / High

69.00

View Chart

Corporate News

Bafna Pharmaceutical - Copy of Newspaper Publication

28-Aug-2025|4:37PM

Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newsp

Bafna Pharmaceutical - Shareholders meeting

26-Aug-2025|6:17PM

Bafna Pharmaceuticals Limited has informed the Exchange regarding Notice of

Bafna Pharmaceutical - Notice Of 30Th Annual General ...

26-Aug-2025|6:03PM

We herewith enclose the Notice of 30th Annual General Meeting of the Compan

Bafna Pharmaceutical - Reg. 34 (1) Annual Report.

26-Aug-2025|5:57PM

We herewith enclose the Annual Report of the Company for the F.Y 2024-2025.

	Promoters 17,742,251	75.00%
	Institutional Investors 2,209,803	9.34%
	Other Investors 956,286	4.04%
	General Public 2,747,995	11.62%

Peer Comparison

Company Name	Price (₹)	Market Cap(₹ Cr)
Aarey Drug	74.22	210.45
Aarti Drug	516.65	4,715.46
Aarti Pharma	900.30	8,160.43
Abbott India	30,890.00	65,639.09
Accent Micro	260.75	625.51

MF Holding

No Data Available

Board Meetings

Date	Purpose
12/08/2025	Quarterly Results
26/05/2025	Audited Results
06/02/2025	Quarterly Results
11/11/2024	Quarterly Results
13/08/2024	Quarterly Results

Markets

BAFNA PHARMACEUTICALS LTD.

Company Information

Management

Mr. A Mohanachandran

Mr. Melagiri Sridhar

Mr. Bafna Mahaveer Chand

Incorporation Year

Registered Address

Registrar Office

Email

Website

Listing